Rotarod Fatigue Protocol
Overview
The rotarod fatigue protocol employs repeated accelerating or constant-speed trials with short inter-trial intervals (typically 60 seconds) to deliberately induce progressive motor fatigue and quantify the rate and magnitude of performance decline across a high-volume session of 10 or more trials. This paradigm engages not only the cerebellar-basal ganglia motor circuits tested in standard rotarod assays but also challenges mitochondrial oxidative capacity in skeletal muscle, neuromuscular junction reliability under sustained demand, and central fatigue mechanisms involving serotonergic modulation in brainstem motor nuclei. The protocol is uniquely sensitive to deficits that only manifest under cumulative exertion, such as myasthenic syndromes, metabolic myopathies, and mitochondrial respiratory chain disorders.
The critical outcome is the fatigue curve: latency to fall plotted against trial number across the entire session. Key derived measures include the fatigue index (ratio of mean latency in the last three trials to the first three trials), the trial at which performance drops below 50% of peak (fatigue threshold), and the area under the fatigue curve (AUC) representing total motor output. The decay constant from an exponential fit to the fatigue curve provides a single parameter summarizing fatigue kinetics. Recovery can be probed by including a final trial after a longer rest period, quantifying the reversible versus irreversible components of fatigue.
ConductMaze manages the high-throughput trial scheduling required for fatigue protocols, automatically cycling animals through consecutive trials with precisely timed inter-trial intervals and logging each fall with millisecond-resolution beam-break detection. The system computes fatigue curves, fits exponential decay models, and calculates fatigue indices in real time, displaying progressive performance decline as a live updating chart during the session. Automated alerts flag animals that show no fatigue (ceiling effect) or fail the first trial (floor effect), prompting parameter adjustment.
Trial Flow
Protocol Configuration
Set number of trials, ITI, speed profile, and fatigue analysis parameters
Baseline Trial
Run first trial to establish baseline performance; place animal on rod at starting speed
Acceleration/Constant
Rod accelerates (4-40 RPM over 300s) or maintains constant speed per protocol variant
Fall Detection
IR sensor detects fall; record latency and RPM; return animal to home cage
Short Rest Interval
Animal rests in home cage for designated ITI (default 60 seconds)
Repeat Trials
Cycle through trials until target count reached; track cumulative fatigue in real time
Recovery Trial
Optional final trial after extended rest (15 min) to assess fatigue reversibility
Session End
Export fatigue curves and summary statistics; clean apparatus between cohorts
Parameters
| Parameter | Type | Default | Description |
|---|---|---|---|
| Number of Trials | integer | 12 | Total number of consecutive trials in the fatigue session |
| Inter-Trial Interval | seconds | 60 | Rest period between consecutive trials in seconds (short to induce fatigue) |
| Speed Profile | enum | accelerating | Accelerating (4-40 RPM) or constant speed per trial |
| Start Speed | integer | 4 | Initial rotation speed in RPM for accelerating variant |
| Max Speed | integer | 40 | Maximum rotation speed in RPM |
| Max Trial Duration | duration | 300 | Maximum single trial length in seconds |
| Recovery Rest Duration | seconds | 900 | Extended rest period before optional recovery trial in seconds |
| Include Recovery Trial | enum | yes | Whether to include a final recovery trial after extended rest |
| Fatigue Window Early | integer | 3 | Number of initial trials used to compute baseline for fatigue index |
| Fatigue Window Late | integer | 3 | Number of final trials used to compute fatigued performance for fatigue index |
Metrics
| Metric | Unit | Description |
|---|---|---|
| Fatigue Index | ratio | Mean latency of last N trials / mean latency of first N trials (lower = more fatigue) |
| Fatigue Threshold Trial | trial # | First trial where latency drops below 50% of peak performance |
| Area Under Fatigue Curve | seconds | Cumulative latency to fall summed across all trials (total motor output) |
| Decay Constant | 1/trial | Exponential decay rate constant fitted to the latency-by-trial curve |
| Peak Latency | seconds | Highest single-trial latency to fall across the entire session |
| Recovery Ratio | ratio | Recovery trial latency / baseline mean latency (1.0 = full recovery) |
| Trial-to-Trial Decline | s/trial | Average latency decrease per successive trial from linear regression |
Sample Data
| Subject | Genotype | Trial | Latency to Fall (s) | Cumulative AUC (s) | RPM at Fall |
|---|
Representative data for illustration purposes. Actual values will vary by species, strain, and experimental conditions.
Applications
- 1Mitochondrial myopathy phenotyping — detecting exercise intolerance in respiratory chain complex knockout mice
- 2Neuromuscular junction disorders — revealing fatigability in myasthenia gravis and Lambert-Eaton syndrome models
- 3Anti-fatigue drug screening — quantifying compounds that slow the rate of motor performance decline under sustained demand
- 4Aging and sarcopenia — tracking age-related increases in motor fatigability as a functional biomarker
- 5Central fatigue mechanisms — dissociating peripheral muscle fatigue from serotonergic brainstem fatigue with pharmacological probes
Related Protocols
Compatible Products
Ready to Automate Your Behavioral Protocols?
Contact us for a demo and pricing information.
